Document is current
Any future updates will be listed below
-
Authors
Llop, Maria
Rios Rodriguez, Valeria
Redeker, Imke
Sieper, Joachim
Haibel, Hildrun
Rudwaleit, Martin
Poddubnyy, Denis https://orcid.org/0000-0002-4537-6015
-
Funding
Funding for this research was provided by:
BMBF (01EC1401A, 01EC1407A)
- License Information
-
More Information
Article History
Received: 7 January 2019
Accepted: 9 May 2019
First Online: 24 May 2019
Ethics approval and consent to participate
: All patients signed an informed consent to participate in GESPIC, and the study was approved by the central ethics committee.
: Not applicable.
: ML: none declaredVRR: consulting fees, speaking fees, and/or honoraria from AbbVie, MSD, and NovartisIR: none declaredJS: consulting fees, speaking fees, and/or honoraria from AbbVie, Janssen, Lilly, MSD, Novartis, Pfizer, Roche, and UCBHH: consulting fees, speaking fees, and/or honoraria from AbbVie, Janssen, MSD, and NovartisMR: consulting fees, speaking fees, and/or honoraria AbbVie, BMS, Celgene, Chugai, Eli Lilly, Janssen, MSD, Novartis, Pfizer, UCBDP: consulting fees, speaking fees, and/or honoraria from AbbVie, BMS, Lilly, MSD, Novartis, Pfizer, Roche, and UCB
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
